Predictive Value of C-Reactive Protein to Albumin Ratio in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.
Halit AcetTuncay GüzelBayram AslanMehmet Ali IsikFaruk ErtasSibel CatalkayaPublished in: Angiology (2020)
The present study aimed to examine the association of C-reactive protein to albumin ratio (CAR) with short-term major adverse cardiac events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). We included 539 STEMI patient treated with pPCI in this study. Patients were divided into 2 groups according to MACE development. Patients with MACE had higher CAR than those without (1.18 [0.29-1.99] vs 0.21 [0.09-0.49], P < .001). Multivariate analysis showed that The Global Record for Acute Coronary Events score, Percutaneous Coronary Intervention with TAXus and cardiac surgery (SYNTAX) score, glucose and CAR (odds ratio:1.326, 95% CI: 1.212-1452, P < .001) were independent predictors of MACE. The CAR may be proven useful for risk stratification in STEMI patients undergoing pPCI.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- patients undergoing
- coronary artery bypass grafting
- cardiac surgery
- coronary artery bypass
- end stage renal disease
- atrial fibrillation
- newly diagnosed
- chronic kidney disease
- acute kidney injury
- heart failure
- liver failure
- emergency department
- left ventricular
- skeletal muscle
- blood pressure
- patient reported
- intensive care unit
- weight loss
- data analysis
- adverse drug